Celltrion, a major Korean biopharmaceutical firm, said Tuesday that its two new biosimilars for bone disease treatment, Stoboclo and Osenvelt, have obtained approval from the United States.

For patients with a rare genetic disorder that turns their muscles into bone, there is new hope. The disease is […] ...

Obese individuals are at a higher risk of developing several health issues including type-2 diabetes, heart disease, ...

It fills in the gaps with new bone, which renews and strengthens the skeletal structure. In Paget’s disease, the balance ...

Celltrion announced Tuesday that its biosimilars Stoboclo and Osenvelt, referencing bone disease treatments Prolia and Xgeva (denosumab), have received marketing approval from the US Food and Drug ...

Clinical research has long focused on ways to harness the actions of the immune system. From vaccines to immunotherapies, ...

Feb. 25, 2025 — A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer ... Feb. 21, 2025 ...

The Unbreakable Boy” and “American Underdog,” both starring Zachary Levi, were shot consecutively in the Oklahoma City area ...

Since you can’t see your bones aging, you should be proactive about preventing osteoporosis. Atrium Health’s Fracture ...

A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...